Mesa Laboratories Stock Forecast, Price & News

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

How has Mesa Laboratories' stock been impacted by Coronavirus?

Mesa Laboratories' stock was trading at $230.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MLAB stock has increased by 36.0% and is now trading at $314.06.
View which stocks have been most impacted by COVID-19.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Mesa Laboratories.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its quarterly earnings results on Thursday, November, 4th. The medical instruments supplier reported $1.49 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.60. The medical instruments supplier earned $35.84 million during the quarter, compared to the consensus estimate of $34.95 million. Mesa Laboratories had a net margin of 3.56% and a trailing twelve-month return on equity of 6.17%.
View Mesa Laboratories' earnings history.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Friday, October 1st. Shareholders of record on Tuesday, November 30th will be paid a dividend of $0.16 per share on Wednesday, December 15th. This represents a $0.64 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date is Monday, November 29th.
View Mesa Laboratories' dividend history.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.20%. The dividend payout ratio of Mesa Laboratories is 68.82%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 9.74% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.
View Mesa Laboratories' dividend history.

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the following people:

• John James Sullivan, Chairman
• Gary M. Owens, President, CEO, COO & Director (LinkedIn Profile)
• John V. Sakys, CFO, Treasurer & Chief Accounting Officer (LinkedIn Profile)
• Peter Jung, Vice President-Strategy & Corporate Development
• Gregory T. DiNoia, Senior Vice President-Commercial Operations (LinkedIn Profile)

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories CEO Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among Mesa Laboratories' employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Mesa Laboratories' key competitors?

Some companies that are related to Mesa Laboratories include Cognex (CGNX), Coherent (COHR), National Instruments (NATI), Badger Meter (BMI), Itron (ITRI), OSI Systems (OSIS), FARO Technologies (FARO), Vishay Precision Group (VPG) and Daktronics (DAKT).
View all of MLAB's competitors.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (17.00%), Conestoga Capital Advisors LLC (9.89%), Invesco Ltd. (4.76%), Kayne Anderson Rudnick Investment Management LLC (3.02%), Schroder Investment Management Group (2.62%) and Geode Capital Management LLC (1.66%). Company insiders that own Mesa Laboratories stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Robert V Dwyer.
View institutional ownership trends for Mesa Laboratories.

Which major investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Two Sigma Investments LP, Invesco Ltd., Morgan Stanley, Marshall Wace LLP, Millennium Management LLC, Eagle Asset Management Inc., and New York State Common Retirement Fund. Company insiders that have sold Mesa Laboratories company stock in the last year include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, and John Sakys.
View insider buying and selling activity for Mesa Laboratories or view top insider-selling stocks.

Which major investors are buying Mesa Laboratories stock?

MLAB stock was bought by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Dimensional Fund Advisors LP, Goldman Sachs Group Inc., Schroder Investment Management Group, Granahan Investment Management Inc. MA, EAM Investors LLC, Raymond James & Associates, and EAM Global Investors LLC.
View insider buying and selling activity for Mesa Laboratories or or view top insider-buying stocks.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $314.06.

How much money does Mesa Laboratories make?

Mesa Laboratories has a market capitalization of $1.64 billion and generates $133.94 million in revenue each year. The medical instruments supplier earns $3.27 million in net income (profit) each year or $0.93 on an earnings per share basis.

How many employees does Mesa Laboratories have?

Mesa Laboratories employs 506 workers across the globe.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is www.mesalabs.com.

Where are Mesa Laboratories' headquarters?

Mesa Laboratories is headquartered at 12100 W 6TH AVE, LAKEWOOD CO, 80228.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at [email protected], or via fax at 303-987-8989.